ADAMS STREET PARTNERS LLC - Q2 2017 holdings

$426 Million is the total value of ADAMS STREET PARTNERS LLC's 13 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 76.9% .

 Value Shares↓ Weighting
PCTY  Paylocity Corporation$221,478,000
+17.0%
4,902,1280.0%51.96%
+11.6%
QTWO BuyQ2 Holdings, Inc.$127,060,000
+6.3%
3,443,275
+0.4%
29.81%
+1.4%
CRVS  Corvus Pharmaceuticals, Inc.$32,517,000
-41.7%
2,687,3810.0%7.63%
-44.4%
CALL  magicJack VocalTec Ltd.$14,233,000
-15.8%
1,976,8610.0%3.34%
-19.7%
BOX NewBox, Inc.cl a$13,617,000746,568
+100.0%
3.20%
OMED  OncoMed Pharmaceuticals, Inc.$6,126,000
-63.8%
1,839,7300.0%1.44%
-65.5%
MOMO BuyMomo Inc.adr$5,374,000
+40.7%
145,400
+29.7%
1.26%
+34.3%
CLVS NewClovis Oncology, Inc$1,759,00018,785
+100.0%
0.41%
ZEN NewZen Desk$1,535,00055,258
+100.0%
0.36%
SENS  Senseonics Holdings, Inc.$1,174,000
+26.0%
652,0400.0%0.28%
+20.1%
NEWR SellNew Relic Inc.$954,000
-10.4%
22,191
-22.7%
0.22%
-14.5%
CPSI NewComputer Programs & Systems, Inc.$261,0007,972
+100.0%
0.06%
VRNS NewVaronis Systems, Inc.$163,0004,384
+100.0%
0.04%
VCYT ExitVeraCyte, Inc.$0-5,405
-100.0%
-0.01%
KTWO ExitK2M, Inc.$0-12,711
-100.0%
-0.06%
APTI ExitApptio, Inc.cl a$0-25,430
-100.0%
-0.07%
GRPN ExitGroupon, Inc.$0-114,350
-100.0%
-0.11%
PTI ExitProteostasis Therapeutics, Inc.$0-158,925
-100.0%
-0.31%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Paylocity Holding Corporation35Q3 202352.0%
Q2 Holdings, Inc. (fka CBG Holdings, Inc.)35Q3 202336.6%
Corvus Pharmaceuticals, Inc.31Q3 202313.7%
Rimini Street, Inc.24Q3 202336.9%
Aptinyx, Inc.20Q1 202317.5%
magicJack VocalTec Ltd.(fka VocalTec Communications Ltd./Ymax Corporation)18Q4 201871.4%
Fusion Pharmaceuticals, Inc.14Q3 202311.4%
OncoMed Pharmaceuticals, Inc.12Q4 20177.5%
Icosavax, Inc.9Q3 202311.6%
Vacasa, Inc.8Q3 202324.0%

View ADAMS STREET PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ADAMS STREET PARTNERS LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aptinyx Inc.June 27, 20235,395,9968.0%
Fusion Pharmaceuticals Inc.February 14, 20222,947,8096.8%
Rimini Street, Inc.February 14, 202223,659,43127.2%
Paylocity Holding CorpFebruary 14, 20201,738,4283.2%
Aptinyx Inc.February 13, 20194,030,62812.0%
Q2 Holdings, Inc.February 13, 20191,643,2753.8%
Corvus Pharmaceuticals, Inc.March 21, 20183,275,61615.5%
MAGICJACK VOCALTEC LTDFebruary 12, 20181,976,86112.3%
RIMINI STREET, INC.October 20, 201722,783,55638.9%
Five9, Inc.February 13, 20171,766,4703.0%

View ADAMS STREET PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13D/A2023-11-24
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-06-27
SC 13D/A2023-06-13
42023-06-08
13F-HR2023-05-15

View ADAMS STREET PARTNERS LLC's complete filings history.

Compare quarters

Export ADAMS STREET PARTNERS LLC's holdings